[CRITERIA OF EFFICACY OF  CHEMOTHERAPEUTIC SUBSTANCES IN EXPERIMENTAL TOXOPLASMOSIS AND THE THERAPEUTIC EFFECT OF THE SPIRAMYCIN-SULFAMETHOXYDIAZINE COMBINATION IN WHITE MICE INOCULATED WITH "TOXOPLASMA GONDII"].
D000818:Animals; D051379:Mice; D012106:Research; D015572:Spiramycin; D013417:Sulfameter; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D014122:Toxoplasma; D014124:Toxoplasmosis, Animal
D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D013417:Sulfameter; D015572:Spiramycin
EXPERIMENTAL LAB STUDY; MICE; SPIRAMYCIN; SULFONAMIDES; TOXOPLASMOSIS, ANIMAL
CRIT'ERES DE L'EFFICACIT'E DES SUBSTANCES CHIMOTH'ERAPEUTIQUES DANS LA TOXOPLASMOSE EXP'ERIMENTALE ET L'EFFET TH'ERAPEUTIQUE DE L'ASSOCIATION SPIRAMYCINE-SULFAM'ETHOXYDIAZINE SUR LES SOURIS BLANCES INOCUL'EES AVEC "TOXOPLASMA GONDII".